170 related articles for article (PubMed ID: 37287312)
1. PlmCas12e (CasX2) cleavage of CCR5: impact of guide RNA spacer length and PAM sequence on cleavage activity.
Armstrong DA; Hudson TR; Hodge CA; Hampton TH; Howell AL; Hayden MS
RNA Biol; 2023 Jan; 20(1):296-305. PubMed ID: 37287312
[TBL] [Abstract][Full Text] [Related]
2. CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY.
Armstrong DA; Hudson TR; Hodge CA; Hampton TH; Howell AL; Hayden MS
bioRxiv; 2023 Jan; ():. PubMed ID: 36711562
[TBL] [Abstract][Full Text] [Related]
3. Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA.
Selkova P; Vasileva A; Pobegalov G; Musharova O; Arseniev A; Kazalov M; Zyubko T; Shcheglova N; Artamonova T; Khodorkovskii M; Severinov K; Fedorova I
RNA Biol; 2020 Oct; 17(10):1472-1479. PubMed ID: 32564655
[TBL] [Abstract][Full Text] [Related]
4. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
[TBL] [Abstract][Full Text] [Related]
5. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
Stephenson AA; Raper AT; Suo Z
J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
[TBL] [Abstract][Full Text] [Related]
7. Increased Efficiency for Biallelic Mutations of the
Lin D; Scheller SH; Robinson MM; Izadpanah R; Alt EU; Braun SE
CRISPR J; 2021 Feb; 4(1):92-103. PubMed ID: 33616448
[TBL] [Abstract][Full Text] [Related]
8. Cas9 specifies functional viral targets during CRISPR-Cas adaptation.
Heler R; Samai P; Modell JW; Weiner C; Goldberg GW; Bikard D; Marraffini LA
Nature; 2015 Mar; 519(7542):199-202. PubMed ID: 25707807
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity.
Cradick TJ; Fine EJ; Antico CJ; Bao G
Nucleic Acids Res; 2013 Nov; 41(20):9584-92. PubMed ID: 23939622
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system.
Zhang B; Lin J; Perčulija V; Li Y; Lu Q; Chen J; Ouyang S
Nucleic Acids Res; 2022 Nov; 50(20):11820-11833. PubMed ID: 36321657
[TBL] [Abstract][Full Text] [Related]
11. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM.
Tang LC; Gu F
Yi Chuan; 2020 Mar; 42(3):236-249. PubMed ID: 32217510
[TBL] [Abstract][Full Text] [Related]
12. Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique.
Ghosh N; Saha I; Sharma N
Gene; 2022 Apr; 818():146136. PubMed ID: 34999179
[TBL] [Abstract][Full Text] [Related]
13. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
14. Targeted gene disruption by CRISPR/xCas9 system in Drosophila melanogaster.
Ni XY; Zhou ZD; Huang J; Qiao X
Arch Insect Biochem Physiol; 2020 May; 104(1):e21662. PubMed ID: 32027059
[TBL] [Abstract][Full Text] [Related]
15. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
[TBL] [Abstract][Full Text] [Related]
16. [Cas9 protein variant VQR recognizes NGAC protospacer adjacent motif in rice].
Xin GW; Hu XX; Wang KJ; Wang XC
Yi Chuan; 2018 Dec; 40(12):1112-1119. PubMed ID: 30559100
[TBL] [Abstract][Full Text] [Related]
17. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
18. An engineered ScCas9 with broad PAM range and high specificity and activity.
Chatterjee P; Jakimo N; Lee J; Amrani N; Rodríguez T; Koseki SRT; Tysinger E; Qing R; Hao S; Sontheimer EJ; Jacobson J
Nat Biotechnol; 2020 Oct; 38(10):1154-1158. PubMed ID: 32393822
[TBL] [Abstract][Full Text] [Related]
19. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
Xu L; Yang H; Gao Y; Chen Z; Xie L; Liu Y; Liu Y; Wang X; Li H; Lai W; He Y; Yao A; Ma L; Shao Y; Zhang B; Wang C; Chen H; Deng H
Mol Ther; 2017 Aug; 25(8):1782-1789. PubMed ID: 28527722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
